CoChat

The DOI matches its Crossref record; 83 of the 89 references it cites were found in a registry or an index; 49 of the 133 sources its claims cite were checked for support.

Creatine Supplementation in Children and Adolescents

Open access
Jagim, Andrew R., Kerksick, Chad M. · 2021 · Nutrients

Published version of a preprint

Abstract

Creatine is a popular ergogenic aid among athletic populations with consistent evidence indicating that creatine supplementation also continues to be commonly used among adolescent populations. In addition, the evidence base supporting the therapeutic benefits of creatine supplementation for a plethora of clinical applications in both adults and children continues to grow. Among pediatric populations, a strong rationale exists for creatine to afford therapeutic benefits pertaining to multiple neuromuscular and metabolic disorders, with preliminary evidence for other subsets of clinical populations as well. Despite the strong evidence supporting the efficacy and safety of creatine supplementation among adult populations, less is known as to whether similar physiological benefits extend to children and adolescent populations, and in particular those adolescent populations who are regularly participating in high-intensity exercise training. While limited in scope, studies involving creatine supplementation and exercise performance in adolescent athletes generally report improvements in several ergogenic outcomes with limited evidence of ergolytic properties and consistent reports indicating no adverse events associated with supplementation. The purpose of this article is to summarize the rationale, prevalence of use, performance benefits, clinical applications, and safety of creatine use in children and adolescents.

Overview

CoChat Summary

TL;DR

This narrative review summarizes creatine use in children and adolescents, covering prevalence, performance effects, clinical applications, and safety. It concludes that creatine is popular among adolescent athletes, appears well tolerated with no adverse events reported in the reviewed adolescent studies, but that randomized safety and efficacy trials in youth are still lacking.

Key findings

  • Prevalence varies widely by population and era: in 2001, 16% of 674 U.S. high school athletes reported prior creatine use (males 23% vs. females 2%); in 2002, 16.7% of 4,011 high school student-athletes reported current or prior use (males 25.3% vs. females 3.9%); in 2012, 34.1% of 9,417 National Health Interview Survey respondents aged ~11 years who used supplements for sports performance self-reported creatine; in 2020, 8.4% of Australian adolescent boys reported current use and 25.7% intended future use.
  • Performance studies in adolescents are limited to swimmers (n = 5) and soccer players (n = 4); most short-duration studies reported improvements in swim bench/sprint performance, dynamic strength, repeat sprinting, dribbling, countermovement jump, and Wingate power, with no adverse events reported.
  • Creatine content: in children given 0.3 g/kg/day for 7 days, intramuscular phosphocreatine increased 13.9% while brain phosphocreatine increased only 2.1%; in Duchenne muscular dystrophy, 5 g/day for 8 weeks increased the phosphocreatine/inorganic phosphate ratio versus placebo (4.7; 95% CI 3.9–5.6 vs. 3.3; 95% CI 2.5–4.2; p = 0.03).
  • Safety: only 22 of 15,274 (0.144%) FDA adverse event reports from 2018–2020 were associated with creatine, and the FDA designated creatine as generally recognized as safe (GRAS), including for older children and adolescents; one 2019 youth soccer study found trends toward airway effects (p = 0.056 and p = 0.070).

Methods

  • Narrative review summarizing the rationale, prevalence of use, performance benefits, clinical applications, and safety of creatine in children (defined as 0–12 years) and adolescents (13–19 years).
  • Evidence drawn from published surveys, controlled performance studies, clinical case reports/trials, and the FDA adverse event reporting system; no new primary data were collected.
  • Main analysis is a qualitative synthesis, with summary tables for performance and clinical studies; no systematic search strategy or meta-analysis is reported.

Limitations

  • The paper states that controlled performance investigations in adolescents are limited, all available performance studies were in swimming or soccer, and most data come from international (non-U.S.) adolescent males.
  • The paper states that no published studies have examined safety in healthy young or adolescent athletic populations, that absence of self-reported adverse events is not confirmation of safety, and that randomized controlled trials in youth are needed.
  • Evident from the text: this is a narrative review without a described systematic search or quality appraisal, and prevalence estimates rely on self-report surveys with varying definitions and populations; the isolated airway findings in the 2019 soccer study were trends, not statistically significant.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu13020664

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

39 Valid · 7 Not valid · 50 Not checked · 29 Own results and interpretations

64 more claims · 20 with their cited sources checked

Create a free account to see all 125 claims and to verify the 5 references still open.

See all claims — free account
  • It may state two separate claims as one. 44
  • Probably not a substantial claim. 19
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 83 references

Cited by

See all 61

Metadata

Authors
Jagim, A. R., & Kerksick, C. M.
Affiliations
Mayo Clinic Health System (US)
Corresponding author
Jagim, Andrew R.
Venue
Nutrients
Publisher
MDPI AG
Published
2021-02-18
Volume
13
Issue
2
Pages
664
ISSN
2072-6643 (ISSN-L)
OpenAlex
W3132722356
Cited by
61
References
89
Citations by year
2026: 14 · 2025: 12 · 2024: 6 · 2023: 14 · 2022: 8 · 2021: 7
FWCI
1.10
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • Preprints.org (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
  • Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Sports Performance and Training
Keywords
creatine supplementation, children, adolescents, youth athletes, ergogenic aids, exercise performance, neuromuscular disorders, metabolic disorders, safety, high-intensity training
MeSH terms
Adolescent, Child, Creatine, Female, Humans, Male, Soccer, Sports, Swimming, Adolescent Nutritional Physiological Phenomena, Dietary Supplements, Athletic Performance, Performance-Enhancing Substances

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Creatine Supplementation in Children and Adolescents. https://app.cochat.ai/papers/10.3390/nu13020664
The paper
Jagim, A. R., & Kerksick, C. M. (2021). Creatine Supplementation in Children and Adolescents. Nutrients. https://doi.org/10.3390/nu13020664

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.